Advanced Instruments Acquires Solentim

Agilent Technologies Acquires Biocare Medical

March 9, 2026

Medical Devices

Agilent Technologies entered into a definitive agreement to acquire Biocare Medical, a global provider of clinical and research pathology solutions, for $950 million in an all-cash transaction. The acquisition expands Agilent’s pathology portfolio—particularly in immunohistochemistry (IHC)—and is expected to be accretive to Agilent’s top-line growth rate, margin profile, and non-instrument revenue mix in Year 1.

Advanced Instruments (Patricia Industries) Completes Acquisition of Nova Biomedical

March 19, 2025

Healthcare Services

Advanced Instruments, a wholly owned subsidiary of Patricia Industries, completed its acquisition of Nova Biomedical for an enterprise value of USD 2.2 billion. The transaction followed regulatory approval and resulted in the combined business operating under the Nova Biomedical name, led by Advanced Instruments’ CEO Byron Selman.

Solmetex, LLC Acquires Impladent Ltd.

June 5, 2023

Dental

Solmetex, LLC acquired Impladent Ltd., a provider of regenerative dental materials including bone grafts and resorbable membranes, to expand its dental product portfolio. The transaction — supported by Solmetex's existing investor Avista Capital Partners — brings nearly 40 years of Impladent expertise into the Solmetex platform; financial terms were not disclosed.

Advanced Instruments Acquires Artel

April 26, 2022

Medical Devices

Advanced Instruments has signed an agreement to acquire Artel, a Westbrook, Maine-based provider of calibration and validation instruments, consumables, software and services for life-science laboratories. The add-on transaction is funded by Patricia Industries and Advanced Instruments (with external debt), values Artel at an upfront ~$85m with contingent payments of up to $55m, and is intended to expand Advanced Instruments' liquid-handling portfolio and R&D capabilities.

Patricia Industries Acquires Advanced Instruments

September 28, 2020

Medical Devices

Patricia Industries, part of Investor AB, has completed the acquisition of US-based Advanced Instruments, a global leader in osmolality testing instrumentation and consumables, from Windjammer Capital. The deal values Advanced Instruments at an enterprise value of USD 780 million; Patricia Industries injected roughly USD 619–620 million of equity for majority ownership. Advanced Instruments (headquartered in Norwood, Massachusetts) serves clinical, biopharmaceutical and food & beverage markets and reported approximately USD 72 million in sales for the 12 months ending June 30, 2020.

Patricia Industries (Investor AB) Acquires Advanced Instruments from Windjammer Capital

September 1, 2020

Medical Devices

Patricia Industries, part of Investor AB, has signed an agreement to acquire Advanced Instruments, LLC from Windjammer Capital for an enterprise value of $780 million. Advanced Instruments, headquartered in Norwood, Massachusetts, is a manufacturer of scientific and analytical instruments serving the clinical, biotechnology and food & beverage markets; the transaction is expected to close in Q4 2020 subject to regulatory approvals.